The nearest clinic is in Chandler

Central Gilbert usually has a direct street route

The Heritage District and nearby areas can use Warner or Ray. These streets run west toward Dobson Road without requiring a freeway. Traffic lights may matter more than the miles at busy times.

Southeast Gilbert residents may use Loop 202 and then Dobson Road. Power Ranch, Trilogy, and Seville have the longer trip. Your starting point decides which route asks less of a sore joint.

The first visit includes an exam and a discussion

The clinician first hears when soreness began and how it limits you. Next comes a check of joint motion, strength, swelling, and tender areas. Take your medicines and any scan you already have.

The exam guides the care discussion. QC Kinetix may discuss regenerative treatments, including PRP, which puts gathered blood parts that help stop bleeding into the sore joint or nearby tissue. The goal is lower soreness and better movement, although no result is promised. You'll use the risks and follow-up details to judge the choice.

Return visits are part of the travel decision

One clinic visit doesn't always end the care. Ask how many checks are expected and whether someone must drive you. You'll then know the full travel burden before agreeing.

Long car rides can tire an aching hip or knee. Shoulder soreness can make driving uncomfortable as well. Planning each return visit protects your time and comfort.

Sources

1. The OARSI non-surgical management guideline evaluated 60 interventions with GRADE methodology and built its recommendations around core treatments - structured exercise, weight management and self-management education - for every patient with knee osteoarthritis, regardless of what else is added.

   Bannuru RR, et al. — OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage, 2019. DOI: 10.1016/j.joca.2019.06.011.

2. In a 480-patient, four-arm, multicenter randomized phase 2/3 trial, none of three orthobiologic cell injections - autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction, or allogeneic umbilical cord tissue-derived mesenchymal stromal cells - was superior to any other, or to a corticosteroid injection control, on pain at 12 months.

   Mautner K, et al. — Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial. Nat Med, 2023. DOI: 10.1038/s41591-023-02632-w.

3. FDA states in its consumer alert that the only FDA-approved stem cell products in the United States are blood-forming stem cells derived from umbilical cord blood, approved for disorders of the blood-forming system, and that NONE of these products - stem cells, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic fluid - has been approved for the treatment of any orthopedic condition, including osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain or shoulder pain.

   US Food and Drug Administration, Center for Biologics Evaluation and Research — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. , 2020.